ziconotide acetate
ziconotide acetate is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including PRIALT. Available dosage form: injection, solution.
Drug Details
- Generic Name
- ziconotide acetate
- Brand Names
- PRIALT
- Application Number
- NDA021060
- Sponsor
- TerSera Therapeutics LLC
- NDC Codes
- 6
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRATHECAL
- Active Ingredients
- ZICONOTIDE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine. PRIALT (ziconotide) solution, intrathecal infusion is an N-type calcium channel antagonist indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine. ( 1 )